Tirzepatide - First in a new class of diabetes medication (Part 1)

madman

Super Moderator
Tirzepatide is a new class of medication for t2d that activates GIP and glp1 receptors. Endocrinologist Dr. Thomas Blevins (MD, FACE) from Texas Diabetes and Endocrinology, Austin, TX, presents data and practical information for clinicians.



Screenshot (18543).png
 


 

hCG Mixing Calculator

HCG Mixing Protocol Calculator

Beyond Testosterone Podcast

Online statistics

Members online
7
Guests online
2,850
Total visitors
2,857

Latest posts

Back
Top